SUPN logo

Supernus Pharmaceuticals, Inc. (SUPN) Accounts payable

annual accounts payable:

$4.59M+$2.62M(+133.55%)
December 31, 2024

Summary

  • As of today (September 16, 2025), SUPN annual accounts payable is $4.59 million, with the most recent change of +$2.62 million (+133.55%) on December 31, 2024.
  • During the last 3 years, SUPN annual accounts payable has fallen by -$4.74 million (-50.84%).
  • SUPN annual accounts payable is now -59.27% below its all-time high of $11.26 million, reached on December 31, 2010.

Performance

SUPN Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

quarterly accounts payable:

$8.21M+$1.14M(+16.16%)
June 30, 2025

Summary

  • As of today (September 16, 2025), SUPN quarterly accounts payable is $8.21 million, with the most recent change of +$1.14 million (+16.16%) on June 30, 2025.
  • Over the past year, SUPN quarterly accounts payable has increased by +$3.59 million (+77.51%).
  • SUPN quarterly accounts payable is now -76.87% below its all-time high of $35.52 million, reached on June 30, 2022.

Performance

SUPN quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

SUPN Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+133.6%+77.5%
3 y3 years-50.8%-76.9%
5 y5 years-54.8%+49.0%

SUPN Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-56.5%+133.6%-76.9%+318.3%
5 y5-year-56.5%+133.6%-76.9%+318.3%
alltimeall time-59.3%+146.2%-76.9%+856.3%

SUPN Accounts payable History

DateAnnualQuarterly
Jun 2025
-
$8.21M(+16.2%)
Mar 2025
-
$7.07M(+54.2%)
Dec 2024
$4.59M(+133.6%)
$4.59M(-28.2%)
Sep 2024
-
$6.39M(+38.1%)
Jun 2024
-
$4.63M(-67.9%)
Mar 2024
-
$14.40M(+633.0%)
Dec 2023
$1.96M(-81.4%)
$1.96M(-42.0%)
Sep 2023
-
$3.39M(-23.0%)
Jun 2023
-
$4.40M(-61.9%)
Mar 2023
-
$11.54M(+9.5%)
Dec 2022
$10.54M(+13.0%)
$10.54M(-34.2%)
Sep 2022
-
$16.02M(-54.9%)
Jun 2022
-
$35.52M(+188.2%)
Mar 2022
-
$12.32M(+32.1%)
Dec 2021
$9.33M(+51.8%)
$9.33M(+2.3%)
Sep 2021
-
$9.13M(+26.2%)
Jun 2021
-
$7.23M(+21.4%)
Mar 2021
-
$5.95M(-3.1%)
Dec 2020
$6.15M(-39.4%)
$6.15M(-45.1%)
Sep 2020
-
$11.19M(+103.0%)
Jun 2020
-
$5.51M(+76.5%)
Mar 2020
-
$3.12M(-69.2%)
Dec 2019
$10.14M(+217.4%)
$10.14M(+228.2%)
Sep 2019
-
$3.09M(-24.3%)
Jun 2019
-
$4.08M(-43.6%)
Mar 2019
-
$7.24M(+126.6%)
Dec 2018
$3.19M(-53.3%)
$3.19M(-67.5%)
Sep 2018
-
$9.84M(+234.3%)
Jun 2018
-
$2.94M(-11.7%)
Mar 2018
-
$3.33M(-51.3%)
DateAnnualQuarterly
Dec 2017
$6.84M(-15.0%)
$6.84M(+9.3%)
Sep 2017
-
$6.26M(-17.4%)
Jun 2017
-
$7.58M(+49.9%)
Mar 2017
-
$5.06M(-37.2%)
Dec 2016
$8.05M(+86.7%)
$8.05M(+200.0%)
Sep 2016
-
$2.69M(+19.7%)
Jun 2016
-
$2.24M(-15.2%)
Mar 2016
-
$2.65M(-38.7%)
Dec 2015
$4.31M(+131.6%)
$4.31M(+53.4%)
Sep 2015
-
$2.81M(-37.8%)
Jun 2015
-
$4.52M(+426.0%)
Mar 2015
-
$859.00K(-53.9%)
Dec 2014
$1.86M(-40.7%)
$1.86M(+18.4%)
Sep 2014
-
$1.57M(-13.3%)
Jun 2014
-
$1.81M(-16.3%)
Mar 2014
-
$2.17M(-31.0%)
Dec 2013
$3.14M(+12.0%)
$3.14M(+33.5%)
Sep 2013
-
$2.35M(+8.3%)
Jun 2013
-
$2.17M(-40.7%)
Mar 2013
-
$3.66M(+30.5%)
Dec 2012
$2.81M(-72.2%)
$2.81M(-73.2%)
Sep 2012
-
$10.48M(+14.3%)
Jun 2012
-
$9.18M(-1.7%)
Mar 2012
-
$9.34M(-20.6%)
Dec 2011
$10.08M(-10.5%)
$11.76M(+28.6%)
Sep 2011
-
$9.15M(-18.8%)
Dec 2010
$11.26M(+80.4%)
$11.26M(-20.1%)
Sep 2010
-
$14.09M(+125.7%)
Dec 2009
$6.24M(+39.7%)
$6.25M
Dec 2008
$4.47M
-

FAQ

  • What is Supernus Pharmaceuticals, Inc. annual accounts payable?
  • What is the all time high annual accounts payable for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. annual accounts payable year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?

What is Supernus Pharmaceuticals, Inc. annual accounts payable?

The current annual accounts payable of SUPN is $4.59M

What is the all time high annual accounts payable for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high annual accounts payable is $11.26M

What is Supernus Pharmaceuticals, Inc. annual accounts payable year-on-year change?

Over the past year, SUPN annual accounts payable has changed by +$2.62M (+133.55%)

What is Supernus Pharmaceuticals, Inc. quarterly accounts payable?

The current quarterly accounts payable of SUPN is $8.21M

What is the all time high quarterly accounts payable for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high quarterly accounts payable is $35.52M

What is Supernus Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?

Over the past year, SUPN quarterly accounts payable has changed by +$3.59M (+77.51%)
On this page